Bioxcel Therapeutics Inc
555 Long Wharf Drive 12th Floor,
New Haven, 6511, CT,
United States
New Haven, 6511, CT,
United States
1 475-238-6837
Life Sciences
Bioxcel Therapeutics Inc Technographics
Bioxcel Therapeutics Inc Technographics, Software Purchases, AI and Digital Transformation Initiatives
Discover the latest software purchases and digital transformation initiatives being undertaken by Bioxcel Therapeutics Inc and its business and technology executives. Each quarter our research team identifies on-prem and cloud applications that are being used by the 183 Bioxcel Therapeutics Inc employees from the public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources.
During our research, we have identified that Bioxcel Therapeutics Inc has purchased the following applications: Microsoft 365 for Collaboration in 2018, DocuSign eSignature for Digital Signing in 2021, Adobe Experience Cloud for Customer Experience in 2021 and the related IT decision-makers and key stakeholders.
Our database provides customer insight and contextual information on which enterprise applications and software systems Bioxcel Therapeutics Inc is running and its propensity to invest more and deepen its relationship with Microsoft , DocuSign , Adobe Systems or identify new suppliers as part of their overall Digital and IT transformation projects to stay competitive, fend off threats from disruptive forces, or comply with internal mandates to improve overall enterprise efficiency.
We have been analyzing Bioxcel Therapeutics Inc revenues, which have grown to $375.0 million in 2024, plus its IT budget and roadmap, cloud software purchases, aggregating massive amounts of data points that form the basis of our forecast assumptions for Bioxcel Therapeutics Inc intention to invest in emerging technologies such as AI, Machine Learning, IoT, Blockchain, Autonomous Database or in cloud-based ERP, HCM, CRM, EPM, Procurement or Treasury applications.
Bioxcel Therapeutics Inc Tech Stack and Enterprise Applications
Bioxcel Therapeutics Inc Collaboration
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| Microsoft | Legacy | Microsoft 365 | Collaboration | Collaboration | n/a | 2018 | 2018 |
In 2018, Bioxcel Therapeutics Inc deployed Microsoft 365 as its Collaboration platform. Microsoft 365 is referenced on the company website and serves as the primary collaboration backbone for the organization, supporting corporate productivity and communications across research, clinical operations, and corporate functions. The deployment frames Microsoft 365 as the central environment for email, real time meetings, and document collaboration.
Microsoft 365 was configured to provide core Collaboration capabilities including hosted email and calendaring, Microsoft Teams for synchronous communication, SharePoint for intranet and document management, OneDrive for individual file sync, and Office applications for authoring. Standard compliance and information governance features native to Microsoft 365, such as retention controls, eDiscovery workflows, and data loss prevention policies, are consistent with the configuration patterns expected in a regulated life sciences setting.
Operational administration is handled within the Microsoft 365 tenant model, with centralized administration, role based access controls, and policy driven governance applied across the employee base. The implementation is surfaced on the public website and is positioned to support cross functional collaboration and controlled information sharing while leveraging Microsoft 365 administration and governance constructs.
|
Bioxcel Therapeutics Inc Content Management
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| DocuSign | Legacy | DocuSign eSignature | Digital Signing | Content Management | n/a | 2021 | 2021 |
In 2021, Bioxcel Therapeutics Inc implemented DocuSign eSignature as a Digital Signing solution on its corporate website. The deployment embeds DocuSign eSignature flows into web pages to capture legally binding signatures and to deliver web-based envelope workflows to external signatories. DocuSign eSignature is configured to use template-driven signature workflows, audit trail capture, and authentication controls that preserve signing order and record provenance.
Operationally the implementation centralizes web-initiated signing for corporate document workflows, including contract execution, vendor agreements, and routine corporate forms, with signature status managed through the DocuSign management console. Governance relies on administrative role controls and configured signing workflows to enforce sequencing and to maintain audit logs for recordkeeping. The integration scope is explicitly the company website, leveraging embedded signing and standard DocuSign eSignature capabilities to support online signature capture and document lifecycle orchestration.
|
Bioxcel Therapeutics Inc CRM
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| Adobe Systems | Legacy | Adobe Experience Cloud | Customer Experience | CRM | n/a | 2021 | 2021 |
In 2021, Bioxcel Therapeutics Inc deployed Adobe Experience Cloud to manage digital experiences on its corporate website, categorized under Customer Experience. The implementation is focused on site-level web content delivery, visitor analytics, and audience engagement touchpoints used by the marketing and communications teams.
Adobe Experience Cloud was configured to deliver content management, analytics instrumentation, personalization and experience orchestration capabilities consistent with Customer Experience functionality, including campaign orchestration and experiment workflows. Operational governance centers on centralized content and campaign workflows owned by marketing, with web operations responsible for tag management and analytics implementation, linking Bioxcel Therapeutics Inc, Adobe Experience Cloud, Customer Experience and the companys marketing and communications business functions through site-level experience management.
|
Bioxcel Therapeutics Inc IaaS
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
Application Hosting and Computing Services | IaaS |
|
2018 | 2018 |
|
|
|
|
|
Application Hosting and Computing Services | IaaS |
|
2021 | 2021 |
|
|
|
|
|
Application Hosting and Computing Services | IaaS |
|
2021 | 2021 |
|
|
|
|
|
Content Delivery Network | IaaS |
|
2019 | 2019 |
|
|
|
|
|
Content Delivery Network | IaaS |
|
2020 | 2020 |
|
Bioxcel Therapeutics Inc CyberSecurity
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
Secure Email Gateways (SEGs) | CyberSecurity |
|
2020 | 2020 |
|
Bioxcel Therapeutics Inc Professional Services
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
PEO (Professional Employer Organization) | Professional Services |
|
2019 | 2019 |
|
IT Decision Makers and Key Stakeholders at Bioxcel Therapeutics Inc
| First Name | Last Name | Title | Function | Department | Phone | |
|---|---|---|---|---|---|---|
|
|
Chief Executive Officer | CXO | Finance | |
|
|
|
Chief Financial Officer & Vice President | CXO | Finance | |
|
|
|
Vice President, Head Of Human Resources | VP | HR | |
|
|
|
Associate Director HRBP | Director | HR | |
|
|
|
Associate Manager Information Technology Support Engineer | Manager | IT | |
|
|
|
Executive Director, Head Information Technology & Management | Director | IT | |
|
Apps Being Evaluated by Bioxcel Therapeutics Inc Executives
APPS RUN THE WORLD tracks software evaluation trends across 2 million companies worldwide, including buyer insights from Bioxcel Therapeutics Inc IT executives and key decision makers. As part of ARTW Buyer Intent and technographics insights, these findings provide useful visibility into the Bioxcel Therapeutics Inc digital transformation priorities and AI adoption trends.
| Date | Company | Status | Vendor | Product | Category | Market |
|---|---|---|---|---|---|---|
| No data found | ||||||
FAQ - APPS RUN THE WORLD Bioxcel Therapeutics Inc Technographics
Bioxcel Therapeutics Inc is a Life Sciences organization based in United States,
with around 183 employees and annual revenues of $375.0 million.
Bioxcel Therapeutics Inc operates a diverse technology stack with applications such as
Microsoft 365, DocuSign eSignature and Adobe Experience Cloud,
covering areas like Collaboration, Digital Signing and Customer Experience.
Bioxcel Therapeutics Inc has invested in cloud applications and AI-driven platforms to optimize efficiency and growth,
collaborating with vendors such as Microsoft, DocuSign and Adobe Systems.
Bioxcel Therapeutics Inc recently adopted applications including
DocuSign eSignature in 2021, Adobe Experience Cloud in 2021 and Amazon EC2 in 2021,
highlighting its ongoing modernization strategy.
APPS RUN THE WORLD maintains an up-to-date database of Bioxcel Therapeutics Inc’s key decision makers and IT executives,
available to Premium subscribers.
Our research team continuously updates Bioxcel Therapeutics Inc’s profile with verified software purchases,
vendor relationships, and digital initiatives identified from public and proprietary sources.
Subscribe to APPS RUN THE WORLD to access the complete Bioxcel Therapeutics Inc technographics profile,
including detailed breakdowns by category, vendor, and IT decision makers.